JAM
ITOS

Jupiter Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Jupiter Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,133
Closed -$236K – 430
2024
Q3 		$236K Hold
23,133
– – ﹤0.01% 390
2024
Q2 		$343K Hold
23,133
– – ﹤0.01% 367
2024
Q1 		$316K Hold
23,133
– – ﹤0.01% 401
2023
Q4 		$253K Sell
23,133
-7,573
-25% -$75.1K ﹤0.01% 438
2023
Q3 		$336K Sell
30,706
-18,215
-37% -$233K ﹤0.01% 450
2023
Q2 		$647K Hold
48,921
– – 0.01% 450
2023
Q1 		$664K Sell
48,921
-9,318
-16% -$167K 0.01% 362
2022
Q4 		$1.14M Buy
58,239
+36,047
+162% +$704K 0.02% 362
2022
Q3 		$423K Buy
+22,192
New +$511K 0.01% 454

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Jupiter Asset Management's ITOS Position: Q4 2024 in Review

Jupiter Asset Management sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 23,133 shares — an estimated $236K sold.

Jupiter Asset Management first reported a position in ITOS in Q3 2022 and held it in 9 quarters. The position peaked at $1.14M in Q4 2022. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Jupiter Asset Management reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 23,133 iTeos Therapeutics shares in Q4 2024, an estimated $236K.
  • Jupiter Asset Management first reported a position in iTeos Therapeutics in Q3 2022 and held it in 9 quarters.
  • Jupiter Asset Management's iTeos Therapeutics position peaked at $1.14M in Q4 2022.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Jupiter Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.